N
NRIX
Nurix Therapeutics, Inc.
17.76
+0.09+0.51%After Hours: 17.76 0.00 0.00%17:40 05/29 EDT
OPEN/PREV CLOSE15.31/15.28
TODAY RANGE14.24-15.58
VOL1.63M
MARKET CAP1.51B
52 WEEK RANGE8.20-22.50
AVG VOL (3M)1.17M
% TURNOVER1.58%
TURNOVER--
P/E (TTM)-4.6329
% RANGE7.79%
EPS(TTM)-3.1600
P/E(FORWARD)-4.8289
P/B3.148
BVPS4.651
DIVIDEND--
P/S17.75
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.38B
SHARES OUTSTANDING103.41M
NEXT EARNINGS07/07-07/13
FREE FLOAT94.20M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Dow Jones·05/18 10:35
Nurix Therapeutics Price Target Maintained With a $30.00/Share by BTIG
TipRanks·05/15 21:11
Nurix Therapeutics Shareholders Back Directors and Governance Proposals
TipRanks·05/15 15:16
Stifel Nicolaus Keeps Their Buy Rating on Nurix Therapeutics (NRIX)
TipRanks·05/13 12:18
Nurix Therapeutics (NRIX) Receives a Buy from Oppenheimer
Barchart·05/13 06:00
Nurix Therapeutics to Participate in Upcoming Investor Conferences
Reuters·05/12 21:06
BRIEF-Nurix Therapeutics Announces Bexobrutideg Oral Presentation
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.